Payer+Provider's Health System Review
September 5, 2019
September 4, 2019
The transaction is expected to be complete in early 2020 following approval by Total Health Care members and state officials.
Following two years of falling margins, the trend has reversed course, with median margins improving more than 10% over 2018.
September 3, 2019
From 1980 through 2018, the FDA approved a total of 126 cancer drugs to treat solid and hematologic tumors.
August 30, 2019
With value-based care, there are more incentives for providers to take SDOH factors into account, but few have a good handle on it.
August 29, 2019
Physician compensation rebounded from a stagnant 2017, but the increase in productivity was negligible.